DeviceTalks Weekly

In this episode of DeviceTalks Weekly, Host Kayleen Brown talks with Joanna Nathan, CEO and Co-Founder of Prana Surgical, about why catching lung nodules earlier requires a right-sized approach to surgical intervention. Nathan explains Prana’s goal of bringing a lumpectomy approach to lung surgery and how the company is developing its technology to localize and remove nodules while preserving surrounding healthy lung tissue. She distinguishes its initial focus on supporting tissue diagnosis from its longer-term vision of potentially treating lung cancer. Nathan also shares lessons from Prana’s first-in-human experience in Australia, including how observing clinicians using the device helped identify design and workflow improvements. Along the way, she discusses her path from bioengineering to entrepreneurship and how lean medtech teams can use AI while maintaining human oversight. In the FOMO interview, Andy Hansen, Global Director of Engineering at ATL Medical, discusses the future of pulsed field ablation and intravascular lithotripsy. We’ll open the episode with this week’s Newsmakers, covering CMR Surgical’s plans following Stryker’s investment, Intuitive’s U.S. procedure growth and quarterly results, Johnson & Johnson’s timeline for its orthopedics spinoff, Abbott’s planned Nutrition business spinoff, and Medtronic’s appointment of a corporate president. Special thanks to ATL Medical for sponsoring this episode of DeviceTalks Weekly. To learn more about how ATL Medical works with medical device companies, visit: ATLMedical.com. *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:00:00) - Message from Kayleen Brown, DeviceTalks(00:02:26) - Start of Newsmakers(00:21:49) - Start of FOMO with Andy Hansen, Global Director of Engineering, ATL Medical(00:32:32) - Start of Keynote with Joanna Nathan, CEO and Co-Founder, Prana Surgical(00:39:39) - Why Earlier Lung Nodule Detection Calls for Right-Sized Intervention(00:45:30) - Prana’s Goal of Bringing a Lumpectomy Approach to Lung Surgery(00:50:00) - Lessons from First-in-Human Cases and Refining Clinical Workflows(00:55:00) - AI Guardrails for MedTech Teams and What’s Next for Prana

In this episode of DeviceTalks Weekly, Host Kayleen Brown welcomes back Rocco De Bernardis, Global President for Soft Tissue Robotic Surgery at Johnson & Johnson, to discuss the company’s OTTAVA™ Robotic Surgical System. De Bernardis explains why OTTAVA’s four robotic arms are integrated into the operating table and how the system’s smaller footprint could give surgical teams more room to work while helping hospitals bring robotic surgery to additional operating rooms. He also shares what Johnson & Johnson learned from OTTAVA’s clinical trial, including how the system performed in different operating-room environments and what the company’s FDA authorization means as it prepares for a commercial rollout with selected U.S. customers. The conversation also explores the technology behind OTTAVA, including its automated setup and docking, surgical instrumentation, and Polyphonic™, an open digital ecosystem designed to connect data from devices and systems across the operating room. De Bernardis discusses how these technologies could improve workflow, support surgical teams and create a foundation for the future of robotic surgery. Catch the 2023 interview with De Bernardis here: https://www.devicetalks.com/hear-why-j-a-vc-discusses-the-impact-of-glp-1-drugs/  Special thanks to this episode's sponsor, Harmonic Drive. To learn more about how Harmonic Drive works with medical device companies, visit harmonicdrive.net. *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:00:00) - Message from Kayleen Brown, Managing Editor, DeviceTalks(00:03:35) - Start of interview with Lee Ginter, Sales Engineering Manager, Harmonic Drive(00:09:01) - Keynote Interview with Rocco De Bernardis, Global President for Soft Tissue Robotic Surgery, Johnson & Johnson(00:09:52) - Why OTTAVA™ Integrates Robotic Arms Into the Operating Table(00:13:35) - What Johnson & Johnson Learned From OTTAVA’s Clinical Trial(00:17:47) - OTTAVA’s Smaller Footprint and Automated Setup(00:21:59) - Designing Surgical Instruments for Greater Efficiency(00:26:21) - Polyphonic™ and the Future of Connected Robotic Surgery

In this episode of DeviceTalks Weekly, Host Tom Salemi talks with Preceptis Medical CEO Dave Carey about his path from MedTech sales to the corner office. Carey shares lessons from launching disruptive technologies at Boston Scientific, Medtronic, Stryker and Pristine Surgical, including what he looks for when hiring salespeople and what it takes to change established clinical workflows. Carey also explains why his new role at Preceptis is personal. After his daughter experienced emergence delirium following anesthesia for an ear tube procedure, Carey was drawn to Hummingbird, Preceptis’ technology for moving ear tube procedures out of the OR and into the physician’s office without general anesthesia. He explains how Preceptis is working with ENTs, pediatricians and parents to drive adoption and why changing even a five-minute procedure requires more than selling a medical device. For more information, visit https://www.hummingbirdeartubes.com. We’ll open the episode with Newmarker’s Newsmakers featuring Mindray, Boston Scientific, Medtronic and Johnson & Johnson MedTech. This episode is sponsored by DeviceTalks Tuesdays Connected Health Series. Register at DeviceTalks.com.  *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:01:13) - A bit of news from Tom Salemi(00:06:18) - Medtronic hires former Recor CEO to run interventional cardiology group(00:08:15) - Mindray looks to fill hospital ventilator gap left by Philips’ exit(00:09:39) - Medtronic strengthens robotic surgery position with Cornerstone deal, analysts say(00:11:15) - Citi downgrades Boston Scientific as cyberattack recovery compounds competitive pressure(00:14:25) - Johnson & Johnson drops LAA assets following suspended pivotal study(00:17:55) - Keynote Interview: Dave Carey, CEO, Preceptis Medical

In this episode, MassDevice Editor Chris Newmarker interviews Shan Jegatheeswaran, Global President, Polyphonic, Johnson & Johnson MedTech, about what’s to come after the transformation brought to the operating room by digital surgery and robotics. Jegatheeswaran reports that a new wave of surgical intelligence could take that transformation much further by connecting devices, data, AI and clinicians across the entire perioperative pathway. Jegatheeswaran explains why the biggest challenges may no longer be technological. Interoperability, economic incentives, governance, change management and trust all have to evolve alongside AI and connected medical devices. We’ll open the episode with this week’s Newmarker’s Newsmakers – Petal Surgical, Boston Scientific, Medtronic, Zimmer Biomet and Abbott. This episode is sponsored by DeviceTalks West. Go to west.devicetalks.com. *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:09:55) - Petal Surgical says its first-in-human incisionless surgery is coming soon and offers a first glimpse of its system(00:12:10) - Boston Scientific could miss guidance over cybersecurity incident(00:15:02) - Medtronic veteran joins Teleflex’s board(00:17:14) - Zimmer Biomet lets go of former Nevro CEO amid leadership restructuring(00:19:32) - Abbott earns FDA approval for new dual-energy ablation catheter(00:22:46) - Shan Jegatheeswaran, Global President, Polyphonic, Johnson & Johnson MedTech

In this episode, Host Tom Salemi sits down with Eliane Schutte, CEO of Xeltis, to discuss a remarkable biomaterial designed to help the body grow its own living blood vessels. Schutte explains how the technology is being used for dialysis patients today and how it could eventually transform coronary bypass surgery, peripheral vascular care and even heart valve replacement. In the FOMO studio, Tom speaks with Katie Grant, VP of MR at Siemens Healthineers North America, about the global helium supply and why the MRI industry is working to reduce its reliance on the increasingly precious gas. They explore how new magnet designs could make MRI systems lighter, more accessible and easier to install in new locations. As always, we’ll open the podcast with the top stories from MassDevice in Newmarker’s Newsmakers, delivered by MassDevice Editor Chris Newmarker. This week, Chris covers Medtronic’s major investment in surgical robotics, Enovis’ acquisition of eCential Robotics, Stryker’s move to strengthen its shoulder portfolio, the rebranding of Johnson & Johnson MedTech, and job shifts at Zoll Medical. *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:04:35) - Zoll Medical is closing a California facility(00:07:33) - Stryker to acquire ZuriMed to boost shoulder offerings(00:09:35) - Enovis to acquire eCential Robotics for €155 million, plans to bring surgical robot to market(00:11:58) - J&J MedTech is rebranding Shockwave Medical(00:14:06) - Medtronic invests $780M in two companies amid Street-beating Q2(00:14:08) - Keynote Interview – Eliane Schutte, CEO, Xeltis(00:17:10) - FOMO – The State of Helium in MR – Katie Clark, Siemens Healthineers

In this podcast episode, Tito Porras, MD, MBA, CEO and co-founder of startup Inner Logic, shares his unusual path to MedTech entrepreneurship with Host Tom Salemi. Dr. Porras was training to become a neurosurgeon at Johns Hopkins when he began questioning the limits of surgeon training. He realized that even better training wouldn't solve the larger problem: there aren't enough surgeons to provide the care patients need. That realization eventually led Porras to entrepreneurship and Inner Logic, which is developing intelligence and simulation infrastructure that can help develop devices with greater autonomy. Porras explains the difference between automation and autonomy, how AI can help devices perceive and adapt to what's happening during a procedure, and why this technology could eventually expand access to surgical care. Dr. Porras also discusses Inner Logic's work with virtual patients and synthetic data, the potential for autonomy across endovascular, orthopedic and surgical applications, and why the future of autonomous surgery will likely arrive through a series of incremental steps rather than one dramatic leap. MassDevice Editor Chris Newmarker kicks off the podcast with Newmarker's Newsmakers, covering the FDA, Haemonetics, Senseonics, Johnson & Johnson MedTech and Medtronic. *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:06:15) - Trump nominates policy aide as next FDA commissioner(00:09:28) - Haemonetics reconnects with CSL in US plasma collection deal(00:13:22) - Senseonics sees activist investor take a major stake(00:16:08) - Johnson & Johnson wins FDA clearance for new robotic bronchoscopy software(00:17:45) - Medtronic faces potential injunction in Applied Medical case(00:22:26) - Keynote Interview – Tito Porras, MD, CEO and Co-Founder of Inner Logic

In this episode of DeviceTalks Weekly, Host Tom Salemi welcomes Kendra Grubb, MD, vice president and chief medical officer of Medtronic’s Structural Heart business. Dr. Grubb fulfilled her childhood ambition of becoming a cardiac surgeon and an interventionalist.In this episode, Dr. Grubb discusses how structural heart has transformed over the past two decades and why she believes the field is approaching another major disruption. She explores the future of transcatheter therapies, the growing role of AI, imaging and robotics, the challenge of treating more patients, and how Medtronic is building a broader structural heart portfolio.Dr. Grubb also shares her unusual journey from cardiac surgeon and academic leader to medtech executive and explains why she believes the next generation of structural heart technology must make advanced therapies more accessible to more patients.This episode is sponsored by Cortland Biomedical. Go to https://www.cortlandbiomedical.com/ to see their work in the structural heart space.MassDevice Editor Chris Newmarker delivers this week’s Newmarker’s Newsmakers – Alcon, Intuitive, Cook Medical, CVRx, and GE HealthCare.To register for Medical Design & Outsourcing’s Min-Vasive MedTech Webinar Series, go here: https://gateway.on24.com/wcc/experience/elitewtwhmedia/2927718/4415899/medical-design-outsourcing. *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

In this episode of the DeviceTalks Weekly podcast, Mobia Medical CEO Richard Foust explains how the “magical” qualities of the company's neurotechnology helped steer it toward an IPO. Mobia Medical’s implantable pulse generator promotes motor skill recovery in patients who have suffered a stroke. The company’s early commercial success has generated modest revenue, but Foust tells host Tom Salemi that “not all revenue is the same,” explaining why a large, untapped and growing market won over venture capital investors a few years ago and public investors this spring. MassDevice Editor Chris Newmarker returns with another edition of Newmarker’s Newsmakers. Tom and Chris repeatedly lament the departure of former Senior Editor Sean Whooley, who recently left MassDevice to pursue other opportunities. Despite his departure, Sean’s reporting remains front and center, as he wrote all five featured stories covering Danaher, Medtronic, Boston Scientific, Integer, Teleflex, and private equity investors. Special thanks to our sponsors of MassDevice’s Diabetes Technology Innovations Special Report: Cadence, Jabil, and Viant Medical! Download the complimentary report here: https://www.massdevice.com/diabetes-technology-innovations-special-report-2026/ *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

In this episode of the DeviceTalks Weekly podcast, we tackle a range of topics related to the surgical robotics industry. In our keynote conversation, Brian Miller, formerly of Intuitive and now CEO of Sovato, discusses the potential of telesurgery, a promising capability of surgical robotic systems that could save lives while reducing costs and improving efficiency across the healthcare system. In our FOMO interview, Christy Gaudet, global head of solutions at Karl Storz, explains the company's decision to discontinue the Asensus Surgical robotics systems and focus on the often under-appreciated art of imaging. Finally, surgical robotics expert Steve Bell shares his top five newsmakers from the Society of Robotic Surgery (SRS) Annual Meeting, including Ottava, AI, and humanoid surgical robots. Host Tom Salemi also interviews Jim Leonard, vice president of sales at Harmonic Drive, the sponsor of this episode. Visit http://HarmonicDrive.net for more information. *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

In this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi is joined by Harith Rajagopalan, MD, PhD, co-founder and CEO of Fractyl Health. Dr. Rajagopalan explains why Fractyl shifted its focus from treating type 2 diabetes to helping former GLP-1 users maintain their weight loss with Revita, an outpatient endoscopic procedure designed to target the root causes of metabolic disease in the duodenum. He also shares new clinical data, the strategy behind Fractyl's pivotal trial, the company's commercialization plans, and why he believes metabolic endoscopy could become an entirely new category of care. This episode is brought to you by the  DeviceTalks Interventional Innovations series, July 28-30th. To register for this complimentary series, click here. *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:01:35) - Keynote Interview - Harith Rajagopalan, MD, PhD, Co-Founder and Chief Executive Officer, Fractyl Health(00:06:26) - Starting with Back of the Napkin Idea(00:18:45) - Why patients are enthusiastic(00:24:35) - The Parallels to Renal Denervation(00:29:40) - Commercial Plans, Pivotal Trials & What's Next